An Update on Coronavirus Therapeutics
For this edition of Community Pulse, Dr. Elizabeth Allemann takes a look at the research on therapeutics related to coronavirus, like Hydroxychloroquine, Remdesivir, Artemesia, Ivermectin, and Convalescent plasma.
Links to resources mentioned in this episode:
- Low Dose of Hydroxychloroquine Reduces Fatality of Critically Ill Patients With COVID-19 (PubMed)
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19 (New England Journal of Medicine)
- Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis (The Lancet)
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro (Science Direct)
- Usefulness of Ivermectin in COVID-19 Illness (SSRN)
- Remdesivir for the Treatment of Covid-19 — Preliminary Report (New England Journal of Medicine)